特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
819224

乱用薬物検査:技術と世界市場

Drugs of Abuse Testing: Technologies and Global Markets

出版日: | 発行: BCC Research | ページ情報: 英文 174 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.49円
乱用薬物検査:技術と世界市場
出版日: 2019年03月29日
発行: BCC Research
ページ情報: 英文 174 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の乱用薬物検査市場は2018年の35億米ドルからCAGR5.6%で拡大し、2023年までに46億米ドルに達すると予測されています。

当レポートでは、世界の乱用薬物検査市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 イントロダクション

第2章 サマリーとハイライト

第3章 市場と技術背景

  • 単回検査とマルチパラメーター検査
  • 乱用薬物スクリーニング
  • 確認検査
  • 尿検査
  • その他の検査方法
  • 検査場所
    • ポイントオブケア
    • オンサイト
  • 試験所検査の試料
  • 検出期間
  • 薬物検査のごまかし
  • 試料有効性検査
  • 偽陽性と偽陰性
  • 検査技術

第4章 市場動向

  • 薬物乱用検査
  • 検査影響因子

第5章 法規制シナリオ

  • 北米
  • 南米
  • 中米・カリブ諸国
  • 欧州
  • アジア太平洋地域

第6章 試料タイプ別市場

  • イントロダクション
  • 尿
  • 血液
  • 口腔液体
  • 毛髪
  • その他

第7章 地域別市場

  • 地域別分析
  • モニタリング市場と予測
  • 北米
  • 欧州
  • その他の諸国

第8章 検査タイプ別市場

第9章 特許分析

第10章 競合環境

第11章 企業プロファイル

第12章 略語

図表

List of Tables

  • Summary Table: Global Market for DOA Testing, by Sample Matrix, Through 2023
    • Table 1: Cutoff Concentrations for Initial and Confirmatory Drug Tests in Urine
    • Table 2: Comparison of Federal Workplace Drug Testing and Clinical Drug Testing
    • Table 3: Advantages and Disadvantages of Point-of-Care Testing
    • Table 4: Major Advantages and Disadvantages of Onsite Testing
    • Table 5: Advantages and Disadvantages of Various Matrices for Drug of Abuse Testing
    • Table 6: Detection Periods for Various Types of Drug Testing
    • Table 7: Common Parameters Tested for Urine Specimen Validity
    • Table 8: Some of the Commercial/Common Adulterants Used in Fooling Urine Tests and Their Effects
    • Table 9: Common Parameters Tested for Urine Specimen Validity
    • Table 10: Commercial/Common Adulterants Used in Fooling Urine Tests and Their Effects
    • Table 11: Methods for Testing Urine Sample Validity
    • Table 12: Cross Reactants That Can Lead to False Positives in DOA Testing
    • Table 13: Clearance Rates for Common DOA
    • Table 14: Commonly Abused Drugs
    • Table 15: Global Number of Illicit Drug Users, 2016
    • Table 16: Number of Drug-related Deaths, Mortality Rates per Million Persons Aged 15-64 Years and Ranking of Drugs as Primary Cause of Death (2016 or Latest Year Available), 2002-2017
    • Table 17: Estimated Number of Drug-Related Deaths and Mortality Rates per Million Persons Aged 15-64 Years, by Region, 2018
    • Table 18: Annual Prevalence, by Region, 2016
    • Table 19: U.S. Drug Testing Legislations, by State, 2017
    • Table 20: Marijuana Legalization in Selected State, 2016
    • Table 21: European Drug Testing Legislation, by Country
    • Table 22: Global Market Share for DOA Testing, by Sample Type, 2017-2023
    • Table 23: Global Market for DOA Testing, by Sample Type, Through 2023
    • Table 24: Urine DOA Testing Products, by Major Players
    • Table 25: Global Market for Urine DOA Testing, by Region, Through 2023
    • Table 26: Global Market for Urine DOA Testing: Laboratory-based versus Onsite, Through 2023
    • Table 27: Blood DOA Testing Products, by Major Players
    • Table 28: Global Market for Blood DOA Testing, by Region, Through 2023
    • Table 29: Global Market for Oral Fluid DOA Testing, by Region, Through 2023
    • Table 30: Global Market for Oral Fluid DOA Testing: Laboratory-based versus Onsite, Through 2023
    • Table 31: Global Market for Hair DOA Testing, by Region, Through 2023
    • Table 32: Global Market for Sweat DOA Testing, by Region, Through 2023
    • Table 33: Global Market for Other DOA Testing Sample Types, by Region, Through 2023
    • Table 34: Global Market for DOA Testing, by Region, Through 2023
    • Table 35: North American Market for DOA Testing, by Sample Type, Through 2023
    • Table 36: Drug Abuse Statistics in the U.S., by Drug Type (Aged 12 and Older), 2016 and 2017
    • Table 37: U.S. Types of Illicit Drug Use in Lifetime, Past Year, and Past Month Among Persons Aged 18 or Older, 2016 and 2017
    • Table 38: U.S. Illicit Drug Use in Lifetime, Past Year, and Past Month, by Detailed Age Category, 2016 and 2017
    • Table 39: U.S. Marijuana Use in Lifetime, Past Year, and Past Month, by Detailed Age Category, 2016 and 2017
    • Table 40: European Market for DOA Testing, by Sample Type, Through 2023
    • Table 41: Annual Prevalence of Opioid Use as a Percentage of the Population Aged 15 to 64, by Country, 2018
    • Table 42: Annual Prevalence of Cocaine Use as a Percentage of the Population Aged 15 to 64, by Country, 2018
    • Table 43: Annual Prevalence of Cannabis Use as a Percentage of the Population Aged 15 to 64, by Country, 2018
    • Table 44: Annual Prevalence of ATS Use as a Percentage of the Population Aged 15 to 64, by Country, 2018
    • Table 45: Annual Prevalence of Ecstasy Use as a Percentage of the Population Aged 15 to 64, by Country, 2018
    • Table 46: RoW Market for DOA Testing, by Sample Type, Through 2023
    • Table 47: Global Market for DOA Testing, by Testing Type, Through 2023
    • Table 48: Global Market for Laboratory-Based DOA Testing, Through 2023
    • Table 49: Global Market for Onsite DOA Testing, Through 2023
    • Table 50: Selected U.S. Patents Granted for DOA Testing, 2007-2018
    • Table 51: Ranking of Companies in the DOA Testing Market, 2018
    • Table 52: Most Notable Mergers and Acquisitions in the DOA Testing Market, 2000-2018
    • Table 53: Major Companies and Their Products in the DOA Testing Market
    • Table 54: Companies Offering Laboratory-based DOA Testing Products
    • Table 55: Main Players in the Onsite DOA Testing Market and Their Products
    • Table 56: Common DOA and Popular Urine Drug Screening Products
    • Table 57: Key Market Players Offering DOA Testing Products on Oral Fluid, Hair and Sweat Sample Types
    • Table 58: One Step Detect Associates: DOA Testing Product Portfolio
    • Table 59: Abbott Diagnostics: Financials, 2015-2017
    • Table 60: ACON Laboratories Inc.: Financials, 2015-2017
    • Table 61: Agilent Technologies: Revenue, 2015-2017
    • Table 62: ALFA Scientific: DOA Testing Product Portfolio
    • Table 63: ABMC: DOA Testing Product Portfolio
    • Table 64: Bio-Rad Laboratories: DOA Testing Product Portfolio
    • Table 65: Confirm Biosciences: DOA Testing Product Portfolio
    • Table 66: Express Diagnostics International Inc.: DOA Testing Product Portfolio
    • Table 67: IDenta Corp.: DOA Testing Product Portfolio
    • Table 68: LifeSign: DOA Testing Product Portfolio
    • Table 69: MedTest DX: DOA Testing Product Portfolio
    • Table 70: MEDTOX Diagnostics: DOA Testing Product Portfolio
    • Table 71: MP Biomedicals: DOA Testing Product Portfolio
    • Table 72: OraSure: DOA Testing Product Portfolio
    • Table 73: Prechek Bio: DOA Testing Product Portfolio
    • Table 74: Princeton BioMeditech: DOA Testing Product Portfolio
    • Table 75: Psychemedics: DOA Testing Product Portfolio
    • Table 76: Quest Diagnostics Inc.: DOA Testing Product Portfolio
    • Table 77: Redwood Toxicology Laboratory: DOA Testing Product Portfolio
    • Table 78: Thermo Fisher Scientific: Recent Financials, 2016-2017
    • Table 79: Thermo Fisher Scientific: DOA Testing Product Portfolio
    • Table 80: UCP Biosciences: DOA Testing Product Portfolio
    • Table 81: Acronyms Used for Drug Testing: Technologies and Global Markets

List of Figures

  • Summary Figure: Global Market Share for DOA Testing, by Sample Matrix, 2018 and 2023
    • Figure 1: Annual Prevalence of the Use of Amphetamines and Prescription Stimulants, by Region, 2018
    • Figure 2: Annual Prevalence of the Use of Cannabis, by Region, 2018
    • Figure 3: Annual Prevalence of the Use of Cocaine, by Region, 2018
    • Figure 4: Illicit Cultivation of Opium Poppy, 2006-2017*
    • Figure 5: Global Market for DOA Testing, by Sample Type, 2017-2023
    • Figure 6: Global Market for Urine DOA Testing, by Region, 2016-2023
    • Figure 7: Global Market for Urine DOA Testing: Laboratory-based versus Onsite, 2016-2023
    • Figure 8: Global Market for Blood DOA Testing, by Region, 2016-2023
    • Figure 9: Global Market for Oral Fluid DOA Testing, by Region, 2016-2023
    • Figure 10: Global Market for Oral Fluid DOA Testing: Laboratory-based versus Onsite, 2016-2023
    • Figure 11: Global Market for Hair DOA Testing, by Region, 2016-2023
    • Figure 12: Global Market for Sweat DOA Testing, by Region, 2016-2023
    • Figure 13: Global Market for Other DOA Testing Sample Types, by Region, 2016-2023
    • Figure 14: Global Market Share for Drugs of Abuse Testing, by Region, 2017
    • Figure 15: Abbott Diagnostics: Recent Financials, 2015-2017
    • Figure 16: Abbott Diagnostics: Revenue Share, by Business Segment, 2017
    • Figure 17: Abbott Diagnostics: Revenue Share, by Country, 2017
    • Figure 18: ACON Laboratories Inc.: Financials, 2015-2017
    • Figure 19: Agilent Technologies: Revenue Share, by Region/Country, 2017
    • Figure 20: Agilent Technologies: Revenue Share, by Business Segment, 2017
    • Figure 21: Thermo Fisher Scientific: Recent Financials, 2015-2017
    • Figure 22: Thermo Fisher Scientific: Revenue Share, by Business Segment, 2017
    • Figure 23: Thermo Fisher Scientific: Revenue Share, by Region, 2017
目次
Product Code: PHM013H

Report Highlights:

The global market for drugs of abuse (DOA) testing should grow from $3.5 billion in 2018 to $4.6 billion by 2023 with a compound annual growth rate (CAGR) of 5.6% for the period of 2018-2023.

DOA testing market for urine sample should grow from $2.0 billion in 2018 to $2.6 billion by 2023 with a CAGR of 5.6% for the period of 2018-2023.

DOA testing market for blood sample should grow from $1.1 billion in 2018 to $1.4 billion by 2023 with a CAGR of 5.2% for the period of 2018-2023.

Report Scope:

The report includes the following -

  • An overview of the technologies, types and significance of DOA testing technologies across the globe
  • Drug abuse statistics in key regions.
  • An analysis of regulatory environments in the North America, Europe and Asia-Pacific regions, with country-specific summaries of national legislation and policies.
  • Technology trends in the DOA testing market.
  • Market size and forecast data by region through 2023 for the DOA testing market.
  • Market size and forecast data by sample matrix through 2023 for the DOA testing market.
  • Market size and forecast data through 2023 by test type (laboratory-based and onside) for the DOA testing market.
  • A patent analysis of equipment and technology related to DOA testing.
  • A description of the competitive landscape for DOA testing, including a company share analyses and ranking and the key strategies of leading market players.
  • Company profiles of leading players in the DOA testing market and their key products.
  • An analysis of leading companies and their successful strategies.

The report excludes the following -

  • Alcohol testing and equipment and devices related to alcohol abuse testing are not covered.
  • Market sizing data does not include sales of breath analyzers.

Report Includes:

  • 32 data tables and 49 additional tables
  • An industry analysis of the global market for drug testing technologies within the pharmaceutical industry
  • Analyses of global market trends, with data from 2017, 2018 and projections of compound annual growth rates (CAGRs) through 2023
  • Statistical information pertaining to drug abuse along with its trends as well as drug classes in key geographic regions
  • Information on leading players in the market and their key products
  • Sales projections through 2023 for drug of abuse testing markets by sample matrix and geographic regions
  • Technological assessment of the current and possible future legislation affecting the market in the U.S. and other emerging economies, and examines the influence of these acts in the development of the industry
  • Company profiles of major global players operating within the drug development market, including Ortho-Clinical Diagnostics, Randox Toxicology, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Thermo Fisher Scientific Inc., Quest Diagnostics, and Abbott Laboratories

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Intended Audience
  • Scope of Report
  • Information Sources and Methodology
  • Geographic Breakdown
  • Analysts' Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Market Context for Drug Testing

Chapter 3: Market and Technology Background

  • Single Tests vs. Multiparameter Tests
  • DOA Screening
  • Confirmation Testing
  • Urine Tests
  • Other Testing Methods
    • Blood Testing
    • Oral Fluid Testing
    • Saliva Testing
    • Sweat Testing
    • Hair Testing
  • Testing Locations
    • Laboratory-based DAT
  • Point-of-Care DATs
  • Onsite Testing
  • Sample Types for Laboratory Testing
    • Urine Testing
    • Hair Testing
    • Saliva/Oral Fluid Testing
    • Blood Testing
    • Sweat Testing
    • Eye Reflex
  • Detection Period
  • Fooling a Drug Test
    • Fooling Urine Testing
    • Fooling Hair Testing
    • Fooling Saliva Testing
  • Sample Validity Tests
  • False Positives and False Negatives
    • False Positives
    • False Negatives
    • Drug Clearance and Testing Window
  • Testing Technologies
    • Immunoassays
    • Enzyme Immunoassay (EIA)
    • Enzyme-linked Immunosorbent Assay (ELISA)
    • Enzyme Multiplied Immunoassay Technology (EMIT)
    • Fluorescence Polarization Immunoassay (FPIA)
    • Radioimmunoassay (RIA)
    • Chromatography
    • Eye Reflex Measurements

Chapter 4: Market Dynamics

  • Drug Abuse Testing
  • Factors Affecting the Market for DOA Testing
    • Drivers of the DOA Testing Market
    • Restraints in the DOA Testing Market

Chapter 5: Regulatory Scenario

  • North America
    • Canada
    • Mexico
    • U.S.
    • State-level Marijuana Legalization
    • U.S. Department of Transportation
    • Drug Testing in the Military
    • Drug Testing for Welfare Recipients and Public Assistance
    • Drug Testing for Individuals Convicted of Drug Felonies
  • South America
    • Bolivia
    • Brazil
    • Colombia
    • Ecuador
    • Guyana
    • Paraguay
    • Peru
  • Central America and the Caribbean
    • Costa Rica
    • Cuba
    • El Salvador
    • Guatemala
    • Haiti
    • Jamaica
    • Nicaragua
    • Panama
    • Honduras
    • The Bahamas
    • The Netherlands Antilles
    • Trinidad and Tobago
  • Europe
    • Bosnia and Herzegovina
    • Denmark
    • France
    • Germany
    • Italy
    • Latvia
    • Norway
    • Romania
    • Sweden
    • Switzerland
    • The Netherlands
    • The U.K.
  • Asia-Pacific
    • Australia
    • Bangladesh
    • Bhutan
    • Cambodia
    • Hong Kong
    • India
    • Japan
    • Maldives
    • Myanmar
    • Nepal
    • New Zealand
    • Singapore
    • South Korea
    • Sri Lanka
    • Taiwan
    • Thailand
    • Vietnam

Chapter 6: Global Drugs of Abuse Testing Market by Sample Type

  • Introduction
  • Global Sales of Urine DOA Testing
  • Global Sales of Blood DOA Testing
  • Global Sales of Oral Fluid DOA Testing
  • Global Sales of Hair DOA Testing
  • Global Sales of Sweat DOA Testing
  • Global Sales of DOA Testing Using Other Sample Types

Chapter 7: Global Drugs of Abuse Testing Market by Region

  • Regional Analysis
  • Total DOA Testing and Drug Monitoring Markets and Forecasts
  • North America
    • Trends in the Trafficking and Use of Illicit Drugs
  • Europe
    • Trends in the Trafficking and Use of Illicit Drugs in Europe
  • Rest of the World
    • Trends in the Use and Trafficking of Illicit Drugs in Rest of the World

Chapter 8: Global Drugs of Abuse Testing Market by Testing Type

  • Growth Trends in Laboratory-Based and Onsite DOA Testing Markets
    • Laboratory-based DOA Testing Market and Forecast
    • Onsite DOA Testing Market and Forecast

Chapter 9: Patent Analysis

Chapter 10: Competitive Landscape

  • Competitive Analysis
  • Key Developments
    • Key Market Players in the DOA Testing Market and Their Products
  • Laboratory-Based DOA Testing Market Segment
  • Onsite DOA Testing Market Segment
  • Common DOA and Popular Devices for Testing Them
  • Companies in the Oral Fluid, Hair and Sweat DOA Testing Segments

Chapter 11: Company Profiles

  • ONE STEP DETECT ASSOCIATES
  • ABBOTT DIAGNOSTICS
  • ACCUTECH
  • ACON LABORATORIES INC.
  • AGILENT TECHNOLOGIES
  • ALFA SCIENTIFIC
  • AMERICAN BIO MEDICA
  • BECKMAN COULTER
  • BIOPHOR DIAGNOSTICS
  • BIO-RAD LABORATORIES
  • BIOSCAN SCREENING SYSTEMS
  • CONFIRM BIOSCIENCES
  • DANAHER CORP.
  • DEVON MEDICAL PRODUCTS
  • ELITECH GROUP
  • EXPRESS DIAGNOSTICS INTERNATIONAL INC.
  • HOFFMANN-LA ROCHE, LTD.
  • IDENTA CORP.
  • LIFELOC TECHNOLOGIES
  • LIFESIGN
  • MAVAND SOLUTIONS
  • MEDTEST DX
  • MEDTOX DIAGNOSTICS
  • MOSSMAN ASSOCIATES
  • MP BIOMEDICALS
  • NANO-DITECH CORP.
  • ORASURE
  • ORTHO CLINICAL DIAGNOSTICS
  • POLYMED THERAPEUTICS
  • PRECHEK BIO
  • PRINCETON BIOMEDITECH
  • PSYCHEMEDICS
  • QUEST DIAGNOSTICS INC.
  • RANDOX LABORATORIES
  • REDWOOD TOXICOLOGY LABORATORY
  • SHIMADZU CORP.
  • SIEMENS HEALTHINEERS
  • THERMO FISHER SCIENTIFIC
  • UCP BIOSCIENCES

Chapter 12: Acronyms

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.